Advertisements



Pfizer"s COVID-19 shot remains highly protective against the coronavirus, longer-term data shows

Six months after early trial participants got their second doses of the jab, Pfizer says the protection from its vaccine is strong and is holding up. A vial of Pfizer and BioNTech's coronavirus vaccine. CHRIS JACKSON/POOL/AFP.....»»

Category: smallbizSource: nytApr 1st, 2021

Promising new data shows Pfizer"s vaccine can overcome its ultra-cold storage requirements, as new research hints at just how effective the shot is

Pfizer and BioNTech announced Friday that they are seeking approval from the FDA to store their COVID-19 vaccine at higher temperatures. Pfizer annou.....»»

Category: smallbizSource: nytFeb 19th, 2021

Moderna just laid out its strategy to fight coronavirus variants and says a new shot is ready to be tested

Moderna shipped a new version of its coronavirus vaccine to the NIH so that it could be tested in people. A nurse prepares a shot of Moderna's COVID-19 vaccine. Hans P.....»»

Category: topSource: businessinsiderFeb 24th, 2021

What pregnant people need to know about COVID-19 vaccine safety, and when they can get the shot

There's little data on the vaccine in pregnant people, who weren't included in clinical trials, but there's reason to.....»»

Category: worldSource: nytFeb 12th, 2021

Moderna is working on a new version of its COVID-19 shot designed to fight the South African variant

Lab testing showed that Moderna's current shot can likely protect people against variants of the disease first found in South Africa and the UK. Moderna's COVID-19 vaccine is one of two th.....»»

Category: dealsSource: nytJan 25th, 2021

The Pfizer COVID-19 vaccine works against the contagious virus variant first found in UK, a new study shows

Pfizer tested its COVID-19 vaccine against a lab-made version of the coronavirus variant found in the UK, with promising results. Vincent Kalut / Photonews via Getty Images The Pfizer-.....»»

Category: topSource: businessinsiderJan 20th, 2021

The UK is making a risky bet to stretch its supply of coronavirus vaccines, and scientists are split on the untested strategy

The UK is giving more people a single dose of the Pfizer and BioNTech vaccine as soon as possible, instead of waiting for a second dose. Paula McMahon prepares a shot of the Pfizer-BioNTech COVID-19 vaccine. .....»»

Category: topSource: businessinsiderDec 30th, 2020

Trump should take a COVID-19 shot to build confidence in the vaccine among his supporters, the White House coronavirus testing czar says

President Donald Trump taking a vaccine would "generate more confidence among the people who follow him so closely," Adm. Brett Giroi.....»»

Category: smallbizSource: nytDec 21st, 2020

First data from trial of Moderna vaccine candidate for coronavirus could come by June: Evercore

The first set of immunogenicity data from the first trial of a potential vaccine to treat the coronavirus that causes COVID-19 could come as early as June, according to Evercore analyst Umer Ruffat. The National Institutes of Health.....»»

Category: topSource: marketwatchMar 16th, 2020

: Booster dose of COVID vaccines to be given to U.K. volunteers in new trial

Thousands of volunteers will be given a third dose of COVID-19 vaccines as part of a clinical trial to examine whether a “booster” shot can protect against COVID-19 and new coronavirus disease variants......»»

Category: topSource: marketwatchMay 20th, 2021

Coronavirus vaccines are more extraordinary in the real world than in trials - even in the face of variants

In Pfizer's case, the shot also seems to yield fewer instances of side effects like headache, fatigue, and muscle pain than it did in clinical trials. A physician injects a patient with the Moderna COVID-19 vaccine. MediaNe.....»»

Category: dealsSource: nytMay 14th, 2021

The US just authorized Pfizer-BioNTech"s coronavirus vaccine for teenagers, making it the first COVID-19 shot OK"d for 12- to 15-year-olds

US health officials hav.....»»

Category: topSource: businessinsiderMay 10th, 2021

Moderna says its COVID-19 vaccine has a 96% efficacy rate in teens who have received one shot

Moderna Inc. said Thursday that initial data fr.....»»

Category: topSource: marketwatchMay 6th, 2021

Pfizer"s COVID-19 vaccine doesn"t affect sperm, preliminary data suggests

Researchers at the Hebrew University of Jerusalem found no abnormalities in the volume, concentration, or motility of the men's sperm after the shot. Crystal Cox/Business Insider A pre-print s.....»»

Category: smallbizSource: nytMay 5th, 2021

Dr. Fauci explains why COVID-19 vaccines work much better than natural immunity to protect you from the coronavirus

Fauci points to several new studies which show COVID-19 vaccines boost protection from concerning variants among people who've had prior infect.....»»

Category: smallbizSource: nytMay 5th, 2021

Ocugen jumps 27% after its COVID-19 vaccine shows potential effectiveness against virus variants

Studies have demonstrated Covaxin's potential effectiveness against coronavirus strains first seen in Brazil, the UK, and India. lechatnoir/Getty Images Shares of Ocugen jumped 27% on Monda.....»»

Category: topSource: businessinsiderMay 3rd, 2021

Ocugen jumps 20% after its COVID-19 vaccine shows potential effectiveness against virus variants

Studies have demonstrated Covaxin's potential effectiveness against coronavirus strains first seen in Brazil, the UK, and India. lechatnoir/Getty Images Shares of O.....»»

Category: smallbizSource: nytMay 3rd, 2021

Photo shows a mass cremation of COVID-19 victims in India as the country struggles with a new surge, and people are dying waiting for help

India is battling a devastating coronavirus surge, and its health system is overwhelmed by people infected. A drone photo shows a .....»»

Category: dealsSource: nytApr 23rd, 2021

The scientist behind Pfizer"s vaccine says people will likely need a 3rd COVID-19 shot and yearly doses

BioNTech's chi.....»»

Category: topSource: businessinsiderApr 22nd, 2021

Johnson & Johnson coronavirus vaccine delivers $100M in sales

Johnson & Johnson raked in $100 million in first-quarter sales from its single-shot COVID-19 vaccine that was put on hold last week by the U.S. Food and Drug Administration......»»

Category: topSource: foxnewsApr 20th, 2021